Goldman Sachs Group Inc Astrazeneca PLC Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Goldman Sachs Group Inc holds 12,046,285 shares of AZN stock, worth $787 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

12,046,285

Previous 12,496,350 3.6%

Holding current value

$787 Million

Previous $975 Million 3.69%

% of portfolio

0.16%

Previous 0.17%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$76.67 - $87.62 $34.5 Million - $39.4 Million	-450,065 Reduced 3.6%	12,046,285 $939 Million
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $14 Million - $17 Million	210,235 Added 1.71%	12,496,350 $975 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $45.9 Million - $52.4 Million	752,637 Added 6.53%	12,286,115 $832 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $27.9 Million - $31.2 Million	449,999 Added 4.06%	11,533,478 $777 Million
Q3 2023 May 14, 2024	SELL	$64.85 - $71.7 $29.2 Million - $32.3 Million	-449,999 Reduced 3.9%	11,083,479 $751 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $31.4 Million - $34.7 Million	483,775 Added 4.56%	11,083,479 $751 Million
Q2 2023 May 14, 2024	BUY	$69.91 - $75.81 $91.8 Million - $99.6 Million	1,313,594 Added 14.15%	10,599,704 $759 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $91.8 Million - $99.6 Million	1,313,594 Added 14.15%	10,599,704 $759 Million
Q1 2023 May 14, 2024	BUY	$63.15 - $71.6 $96.9 Million - $110 Million	1,534,625 Added 19.8%	9,286,110 $645 Million
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $96.9 Million - $110 Million	1,534,625 Added 19.8%	9,286,110 $645 Million
Q4 2022 May 14, 2024	BUY	$54.21 - $70.44 $54.3 Million - $70.5 Million	1,000,884 Added 14.83%	7,751,485 $526 Million
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $54.3 Million - $70.5 Million	1,000,884 Added 14.83%	7,751,485 $526 Million
Q3 2022 May 14, 2024	BUY	$53.02 - $135.75 $18.3 Million - $46.9 Million	345,216 Added 5.39%	6,750,601 $370 Million
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $18.3 Million - $46.9 Million	345,216 Added 5.39%	6,750,601 $370 Million
Q2 2022 May 14, 2024	SELL	$59.26 - $71.14 $304 Million - $365 Million	-5,128,093 Reduced 44.46%	6,405,385 $423 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $48.9 Million - $58.7 Million	-825,637 Reduced 11.42%	6,405,385 $423 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $52.9 Million - $63.7 Million	948,560 Added 15.1%	7,231,022 $480 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $283 Million - $335 Million	-5,241,096 Reduced 45.48%	6,282,462 $366 Million
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $640 Million - $701 Million	11,523,558 New	11,523,558 $692 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Astrazeneca PLC Transaction History